Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
EMBL European Molecular Biology Laboratory
EMBL European Molecular Biology Laboratory
Activities:
Media
Research & Development
X
LinkedIn
Trending Articles
IMPACT CKD model reveals the escalating toll of chronic kidney disease
The model projects up to 125 million of the population across eight countries to suffer from chronic kidney disease by 2032
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Isospec Analytics launches biomolecular analysis technology to identify unknown molecules
The novel technology optimises the identification process of unknown molecules compared to mass analysis
Building strong foundations for a resilient and planet-friendly future
Having recently released its inaugural environmental, social and governance (ESG) report, Dr Kevin Robinson caught up with Gigi Bat-Erdene, Global ESG Program Manager at PCI...
ten23 health and Ypsomed collaborate to commercialise the YpsoDose patch injector
The partnership will bring the drug delivery device to the pharmaceutical market quicker, whilst reducing development risks
Upcoming event
Making Pharmaceuticals
23–24 April 2024 | Exhibition | Coventry, UK
See all
Related Content
Manufacturing
Bio-Rad joins EMBL’s Corporate Partnership Programme
Corporate Partnership Programme is designed to create long-term relationships between EMBL scientists and its corporate partners, like Bio-Rad
Finance
EMBL Ventures portfolio company, Luxendo, acquired by Bruker
The acquisition, just one and a half years after the company’s creation, allows wider application of Luxendo's Single Plane Illumination Microscopy
Research & Development
Sartorius enters into a corporate partnership programme with the European Molecular Biology Laboratory (EMBL)
Sartorius and EMBL join forces to offer advanced training and science education, aiming to connect industry to academia
Research & Development
Merck and the European Molecular Biology Laboratory agree three-year drug discovery collaboration
Focus on cancer metabolism aims to deliver novel therapeutic targets and biomarkers
Research & Development
Open access platform accelerates drug discovery and development
A web interface to help researchers find therapeutic targets for new and repurposed medicines is now available from the Centre for Therapeutic Target Validation
Research & Development
EMBL-EBI appoints Joint Directors
Ewan Birney and Rolf Apweiler move up from Joint Associate Directors on 1 July
Regulatory
Consortium creates active molecule data standard
Researchers can enter discoveries in a public template and shared database
Subscribe now